Start Fast, Scale Seamlessly: Why A Different Oncology Model Was Needed

Oncology development today rewards speed, but it punishes fragmentation. As early-phase programs move quickly into expanded cohorts, global sites, and more complex protocols, many sponsors find their initial momentum slipping away. Traditional operating models often contribute to the problem: large CRO structures prioritize scale over continuity, while boutique oncology teams excel early but strain under expansion. The result is constant realignment, duplicated effort, and slower decision-making. A different approach starts with the assumption that oncology programs will only grow more complex and designs for that reality from day one. By embedding continuity across teams, data, and oversight, sponsors can preserve early decision context and move forward with confidence as trials scale.

Explore how an oncology-specific operating model helps programs maintain momentum from first-in-human through commercialization.